(Q34719524)

4 August 2017

1 reference

title

Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata (English)

1 reference

4 August 2017

0 references

1 reference

2

Aydin Arici

1 reference

4 August 2017

Ibrahim Sozen

1

1 reference

PubMed ID

12095482

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

4 August 2017

Fertility and Sterility

1 reference

4 August 2017

78

1 reference

4 August 2017

1

1 reference

4 August 2017

1-12

1 reference

Hysterectomy in the United States, 1988-1990.

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Estrogen-Induced Guinea Pig Model for Uterine Leiomyomas: Do the Ovaries Protect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Ultrastructural study of cultured smooth muscle cells from uterine leiomyoma and myometrium under the influence of sex steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Matrix metalloproteinases as mediators of reproductive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Growth factors and cytokines in uterine leiomyomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Expression and hormonal regulation of monocyte chemotactic protein-1 in myometrium and leiomyomata.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Binding Sites for Epidermal Growth Factor in Human Uterine Tissues and Leiomyomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Isolation and Characterization of Heparin-Binding Growth Factors in Human Leiomyomas and Normal Myometrium1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Prolactin production from proliferative phase leiomyoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Decidual-type prolactin expression by the human myometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Decreased prolactin secretion by explant cultures of fibroids from women treated with a gonadotropin-releasing hormone agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Onapristone Suppresses Prolactin Production in Explant Cultures of Leiomyoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Insulin-like growth factor I and II binding in human myometrium and leiomyomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

In vivo regulation of parathyroid hormone-related peptide messenger ribonucleic acid in the rat uterus by 17 beta-estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Growth regulatory properties of endothelins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Differential expression of mRNAs for endothelin-related proteins in human endometrium, myometrium and leiomyoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Smooth muscle cell and endothelial cell growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

HCG promotes proliferation of uterine leiomyomal cells more strongly than that of myometrial smooth muscle cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

The transforming growth factor-beta family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, TGF beta 3, and TGF beta type II receptor messenger ribonucleic acid and protein and contains [125I]TGF beta 1-binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Mitotic activity in uterine leiomyomas during the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

A comparative ultrastructural study of leiomyosarcoma, cellular leiomyoma, and leiomyoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Proliferative activity of human uterine leiomyoma cells as measured by automatic image analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Histopathological changes in leiomyomata treated with leuprolide acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Progesterone therapy in uterine fibromyoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

The progesterone therapy of human uterine leiomyomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

The effectiveness of medroxyprogesterone in the treatment of multiple metastasizing leiomyosarcomas: report of a case.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Autocrine secretion and malignant transformation of cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

The expression of transforming growth factor-beta s and TGF-beta receptor mRNA and protein and the effect of TGF-beta s on human myometrial smooth muscle cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Insulin-like growth factor I promotes leiomyoma cell growth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Involvement of parathyroid hormone-related peptide in cell proliferation activity of human uterine leiomyomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Prolactin Is an Autocrine or Paracrine Growth Factor for Human Myometrial and Leiomyoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Collagen metabolism in gynecologic patients: changes in the concentration of the aminoterminal propeptide of type III procollagen in serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Cell surface interactions with extracellular materials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Alteration of cell-surface proteins by viral transformation and by proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Specific changes in the collagen phenotype of BALB 3T3 cells as a result of transformation by sarcoma viruses or a chemical carcinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Role of laminin in the attachment of PAM 212 (epithelial) cells to basement membrane collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

"Matrix algebra" heals life's wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Transforming growth factor-beta: activity and efficacy in animal models of wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Proteoglycans and neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Involution of keloid implants in athymic mice treated with pirfenidone or with triamcinolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Interferon-alpha is a potent inhibitor of basic fibroblast growth factor-stimulated cell proliferation in human uterine cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Inhibition of mitogenic activity of PDGF, EGF, and FGF by interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Remarkable and persistent shrinkage of uterine leiomyoma associated with interferon alfa treatment for hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Heparin inhibits proliferation of myometrial and leiomyomal smooth muscle cells through the induction of alpha-smooth muscle actin, calponin h1 and p27.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

Heparin-like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903154-0

10.1016/S0015-0282(02)03154-0

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12095482